Ashwagandha and Kidney Transplant Rejection

How it was studied

Design

Case report (indexed by PubMed)

Studied in

People

Main outcome

Clinical events such as disease or death

Who paid for it

Funding

Independent funding

University or hospital

Department of Medicine, Ottawa Hospital

Based on 1 listed funder(s) and full-text disclosure statement.

Publication

Published

2020-10-03 · Kidney Int Rep · vol. 5 · issue 12 · pp. 2375–2378

Publisher

Elsevier BV

Cited

4 citations · more than 16% of similar papers · 0.0× the field average

References

9 works

Access

Open access (journal) · CC-BY-NC-ND

Research areas

Phytochemicals and Medicinal Plants · Complementary and Alternative Medicine Studies · Medicinal Plants and Neuroprotection

Keywords

Medicine, Organ transplantation, Graft rejection, Kidney transplant, Adverse effect, Kidney transplantation, Nephrectomy, Kidney, Transplant rejection, Immune system, Transplantation, Intensive care medicine, Surgery, Internal medicine, Immunology

5 authors

From CA

• Sriram SriperumbuduriUniversity of Ottawa; Ottawa Hospital
• Mishaal Shahid UmarUniversity of Ottawa
• Ginette Lajoie-StarkellUniversity of Ottawa; Canadian Electricity Association
• Todd FairheadUniversity of Ottawa; Ottawa Hospital
• Swapnil Hiremath · correspondingUniversity of Ottawa; Ottawa Hospital

Abstract

Europe PMC has no abstract for this paper. Open the source to read it.

Abstract via Europe PMC. Copyright remains with the authors or publisher (CC BY-NC-ND).

Community trust

Loading…

How much do you trust this study's findings?

Comments

Something wrong here?

Flag this study if its information, labels or funding look wrong. An editor reviews every flag.